389 related articles for article (PubMed ID: 21098704)
1. Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.
Gilad O; Nabet BY; Ragland RL; Schoppy DW; Smith KD; Durham AC; Brown EJ
Cancer Res; 2010 Dec; 70(23):9693-702. PubMed ID: 21098704
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR.
Schoppy DW; Ragland RL; Gilad O; Shastri N; Peters AA; Murga M; Fernandez-Capetillo O; Diehl JA; Brown EJ
J Clin Invest; 2012 Jan; 122(1):241-52. PubMed ID: 22133876
[TBL] [Abstract][Full Text] [Related]
3. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
4. ATR and H2AX cooperate in maintaining genome stability under replication stress.
Chanoux RA; Yin B; Urtishak KA; Asare A; Bassing CH; Brown EJ
J Biol Chem; 2009 Feb; 284(9):5994-6003. PubMed ID: 19049966
[TBL] [Abstract][Full Text] [Related]
5. Glucose deprivation is associated with Chk1 degradation through the ubiquitin-proteasome pathway and effective checkpoint response to replication blocks.
Kim AJ; Kim HJ; Jee HJ; Song N; Kim M; Bae YS; Chung JH; Yun J
Biochim Biophys Acta; 2011 Jun; 1813(6):1230-8. PubMed ID: 21440578
[TBL] [Abstract][Full Text] [Related]
6. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Song H; Hollstein M; Xu Y
Nat Cell Biol; 2007 May; 9(5):573-80. PubMed ID: 17417627
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of human claspin-mediated phosphorylation of Chk1 by the ATR (ataxia telangiectasia-mutated and rad3-related) checkpoint kinase.
Lindsey-Boltz LA; Serçin O; Choi JH; Sancar A
J Biol Chem; 2009 Nov; 284(48):33107-14. PubMed ID: 19828454
[TBL] [Abstract][Full Text] [Related]
8. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.
Liu Q; Guntuku S; Cui XS; Matsuoka S; Cortez D; Tamai K; Luo G; Carattini-Rivera S; DeMayo F; Bradley A; Donehower LA; Elledge SJ
Genes Dev; 2000 Jun; 14(12):1448-59. PubMed ID: 10859164
[TBL] [Abstract][Full Text] [Related]
9. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
Das KC; Dashnamoorthy R
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L87-97. PubMed ID: 12959929
[TBL] [Abstract][Full Text] [Related]
10. Requirement of MTA1 in ATR-mediated DNA damage checkpoint function.
Li DQ; Ohshiro K; Khan MN; Kumar R
J Biol Chem; 2010 Jun; 285(26):19802-12. PubMed ID: 20427275
[TBL] [Abstract][Full Text] [Related]
11. Tim-Tipin dysfunction creates an indispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis.
Smith KD; Fu MA; Brown EJ
J Cell Biol; 2009 Oct; 187(1):15-23. PubMed ID: 19805627
[TBL] [Abstract][Full Text] [Related]
12. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
[TBL] [Abstract][Full Text] [Related]
13. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
14. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
Sørensen CS; Syljuåsen RG; Lukas J; Bartek J
Cell Cycle; 2004 Jul; 3(7):941-5. PubMed ID: 15190204
[TBL] [Abstract][Full Text] [Related]
15. Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.
Rocha S; Garrett MD; Campbell KJ; Schumm K; Perkins ND
EMBO J; 2005 Mar; 24(6):1157-69. PubMed ID: 15775976
[TBL] [Abstract][Full Text] [Related]
16. Mouse tissues that undergo neoplastic progression after K-Ras activation are distinguished by nuclear translocation of phospho-Erk1/2 and robust tumor suppressor responses.
Parikh N; Shuck RL; Nguyen TA; Herron A; Donehower LA
Mol Cancer Res; 2012 Jun; 10(6):845-55. PubMed ID: 22532587
[TBL] [Abstract][Full Text] [Related]
17. ATR-Chk1 pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine.
Heffernan TP; Kawasumi M; Blasina A; Anderes K; Conney AH; Nghiem P
J Invest Dermatol; 2009 Jul; 129(7):1805-15. PubMed ID: 19242509
[TBL] [Abstract][Full Text] [Related]
18. ATR-p53 restricts homologous recombination in response to replicative stress but does not limit DNA interstrand crosslink repair in lung cancer cells.
Sirbu BM; Lachmayer SJ; Wülfing V; Marten LM; Clarkson KE; Lee LW; Gheorghiu L; Zou L; Powell SN; Dahm-Daphi J; Willers H
PLoS One; 2011; 6(8):e23053. PubMed ID: 21857991
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia activates tumor suppressor p53 by inducing ATR-Chk1 kinase cascade-mediated phosphorylation and consequent 14-3-3γ inactivation of MDMX protein.
Lee JH; Jin Y; He G; Zeng SX; Wang YV; Wahl GM; Lu H
J Biol Chem; 2012 Jun; 287(25):20898-903. PubMed ID: 22556425
[TBL] [Abstract][Full Text] [Related]
20. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
Li J; Sejas DP; Burma S; Chen DJ; Pang Q
Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
